Who
Bryan Ball
Officer
Company insider
Files Form 4 as: Officer, Whitehawk Therapeutics; Chief Qual. Officer & SVP Ops., Intercept Pharmaceuticals; Chief Quality Officer, Immunomedics.
In numbers
- Trades disclosed
- 51
- Buys
- 2
- Sells
- 6
- Bought
- $138K
- Sold
- $1.3M
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 5 Mar 2019
- Last trade
- 15 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 18 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,633 at $0.00 | filing |
| 15 Sep 2026filed 18 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,633 at $0.00 | filing |
| 15 Sep 2026filed 18 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,633 at $0.00 | filing |
| 15 Sep 2026filed 18 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,633 at $0.00 | filing |
| 15 Sep 2026filed 15 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,633 at $0.00 | filing |
| 15 Sep 2026filed 15 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,633 at $0.00 | filing |
| 15 Sep 2026filed 15 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,633 at $0.00 | filing |
| 15 Sep 2026filed 15 Sep 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,633 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code A | $200K51,020 at $3.92 | filing |
| 14 May 2026filed 18 May 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code A | $200K51,020 at $3.92 | filing |
| 14 Apr 2026filed 15 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Sold | $337K92,460 at $3.64 | filing |
| 14 Apr 2026filed 15 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Sold | $337K92,460 at $3.64 | filing |
| 13 Apr 2026filed 15 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Sold | $91K26,389 at $3.46 | filing |
| 13 Apr 2026filed 15 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Sold | $91K26,389 at $3.46 | filing |
| 10 Apr 2026filed 13 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Sold | $23K6,596 at $3.43 | filing |
| 10 Apr 2026filed 13 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Sold | $23K6,596 at $3.43 | filing |
| 9 Apr 2026filed 13 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Sold | $179K50,000 at $3.57 | filing |
| 9 Apr 2026filed 13 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Sold | $179K50,000 at $3.57 | filing |
| 1 Apr 2026filed 3 Apr 2026 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code M | —366,532 | filing |
| 1 Apr 2026filed 3 Apr 2026 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —366,532 at $0.00 | filing |
News
Financial Review: Whitehawk Therapeutics (NASDAQ:WHWK) and BeyondSpring (NASDAQ:BYSI)WHWK · dailypolitical.com · 17 Oct 2026Head to Head Analysis: Whitehawk Therapeutics (NASDAQ:WHWK) vs. Surrozen (NASDAQ:SRZN)WHWK · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Bryan Ball; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.